LAIYI
DEAD

Serial Number

76682430

Owner

ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY

Attorney

JACK MATALON

First Use Date

Jun 17, 2009

Filing Date

Oct 1, 2007

Add to watchlist:

No watchlists yet
View on USPTO

LAIYI Trademark

Serial Number: 76682430 • Registration: 3767764

LAIYI is a trademark filed by ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY on October 1, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY (10 trademarks)

59 Huancheng East Road
Zhejiang Province 312500 , CN

Entity Type: 03

Trademark Details

Filing Date

October 1, 2007

Registration Date

March 30, 2010

First Use Anywhere

June 17, 2009

First Use in Commerce

June 17, 2009

Published for Opposition

August 19, 2008

Cancellation Date

November 4, 2016

Goods & Services

Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets; ace-inhibitors; adrenergic agonists; adrenergic blockers; anabolics; analgesics, narcotic and non-narcotic analgesics; anesthetics; antianorexics; antacids; anthelmintics; antiacnes; antiallergics; antianginals; antiarthritics and antirheumatics; antiasthmatics; antibacterials; antibiotics; anticoagulants; anticonvulsants; antidepressants; antidiabetics; antidiarrheals; antidiuretics; antiemetics; antifungals; antiglaucomas; antihistaminics; antihypertensives; antihyperthyroids; antihypotensives; anti-inflammatories; anti-itch creams, ointments and sprays; antimalarials; antimigraines; antimuscarinics; antineoplastics; antioxidants; antiparkinsonians; antiprotozoals; antipruritics; antipsoriatics; antipsychotics; antiseborrheics; antiseptics; antispasmodics; antisyphilitics; antithrombotics; antitussives; antiulceratives; antivirals; anxiolyties; astringents; bacteriostats for medicinal, dental and veterinary use; bath salts for medical purposes; beta-blockers; biocides; biological and chemical reagents for medical or veterinary use; bronchodilators; burn-relief medications; calcium channel blockers; cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; chemotherapeutics; choleretics; cholesterol reducers; cholinergics; cholinesterase inhibitors; cleansing solutions for medical use; clinical medical reagents; CNS stimulants; contraceptives; decongestants; dermatologicals; diagnostic preparations for medical purposes; dietary and nutritional supplements; diuretics; dopamine receptor agonists; enzyme cofactors; estrogens; expectorants; food supplements; gastric and pancreatic preparations; germicides; glucosidase inhibitors; gonad-stimulating principles; hematinics; hematopoietics; hemostatics; hepatoprotectants; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; homeopathic supplements; immunomodulators; immunosuppressants; laxatives; medicinal herbal extracts; mineral nutritional supplements; mineralocorticoids; mixed vitamin preparations; mucolytics; multi-vitamin preparations; muscle relaxants; mydriatics; neutraceuticals for use as dietary supplements; nootropics; nutritional additives to foodstuffs for animals, for medical purposes; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; plant extracts for medical, veterinary and pharmaceutical purposes; processed food adapted for medical purposes; progestogens; prolactin inhibitors; prostaglandins and prostaglandin analogs; dietary supplements; respiratory stimulants; reverse transcriptase inhibitors; sedatives; seratonin receptor agonists and antagonists; soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; vasodilators; vasoprotectants; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 4, 2016 C8..
REGISTERED-PRINCIPAL REGISTER
Mar 30, 2010 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Feb 23, 2010 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 22, 2010 CNPR
AMENDMENT FROM APPLICANT ENTERED
Feb 22, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2010 CRFA
PAPER RECEIVED
Feb 19, 2010 MAIL
NON-FINAL ACTION MAILED
Oct 27, 2009 CNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 26, 2009 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 23, 2009 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2009 AITU
USE AMENDMENT FILED
Oct 6, 2009 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 6, 2009 EISU
SOU EXTENSION 1 GRANTED
Apr 28, 2009 EX1G
SOU EXTENSION 1 FILED
Apr 28, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 28, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 11, 2008 NOAM
PUBLISHED FOR OPPOSITION
Aug 19, 2008 PUBO
NOTICE OF PUBLICATION
Jul 30, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 15, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2008 CNSA
EXAMINERS AMENDMENT MAILED
Jul 14, 2008 CNEA
EXAMINER'S AMENDMENT ENTERED
Jul 14, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 14, 2008 CNEA
FINAL REFUSAL MAILED
Jul 10, 2008 CNFR
FINAL REFUSAL WRITTEN
Jul 9, 2008 CNFR
ASSIGNED TO EXAMINER
Jul 2, 2008 DOCK
AMENDMENT FROM APPLICANT ENTERED
Jun 13, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2008 CRFA
ASSIGNED TO LIE
Jun 11, 2008 ALIE
FAX RECEIVED
Jun 10, 2008 FAXX
FAX RECEIVED
Jun 10, 2008 FAXX
FAX RECEIVED
Jun 10, 2008 FAXX
NON-FINAL ACTION MAILED
Jan 10, 2008 CNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2008 CNRT
ASSIGNED TO EXAMINER
Jan 7, 2008 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 13, 2007 MAFR
NEW APPLICATION ENTERED
Oct 9, 2007 NWAP